Speaker illustration

Mr Alexander James Spicer

University of Turku, Turku (Finland)

Alexander Spicer is currently a key member of the Business Development team within Faron Pharmaceuticals, a Finnish Biotechnology company focused on developing therapies which modulate the immune system to treat diseases with major burden such as cancers. Alex had a successful career in sales within the Pharmaceutical Industry prior to returning to education. He is currently finalising his Masters in Drug Discovery and Development at the University of Turku in Finland with his thesis on the how the route of administration effects the pharmacodynamics of Interferon.

Induction of CD73 prevents death after emergency open aortic surgery

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Drugs, Drug Targets

Session: Poster Session 2


ESC 365 is supported by